5
Registered trials
5
Recruiting
4
Unique sponsors
20
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
H
Endocrinology (ATC H)
1
N
Neurology/Psychiatry (ATC N)
1
R
Respiratory (ATC R)
1
C
Cardiology (ATC C)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
16 substances
Corticosteroid
3 substances
JAK inhibitor
1 substance
Phase III:
1
Phase II:
3
Phase I (First in Human):
1
Phase III
1 trial-
RecruitingRheacell GmbH & Co. KG CommercialALLOGENEIC SKIN-DERIVED ABCB5-POSITIVE DERMAL MESENCHYMAL STROMAL CELLS; CETIRIZINE DIHYDROCHLORIDE; CHLOROPYRAMINE HYDROCHLORIDE; CHLORPHENAMINE MALEATE; CLEMASTINE FUMARATE; DESLORATADINE; DEXCHLORPHENIRAMINE MALEATE; DIPHENHYDRAMINE HYDROCHLORIDE; FEXOFENADINE HYDROCHLORIDE; HYDROCORTISONE SODIUM PHOSPHATE; LEVOCETIRIZINE DIHYDROCHLORIDE; LORATADINE; METHYLPREDNISOLONE; PREDNISOLONE SODIUM SUCCINATE; PROMETHAZINE HYDROCHLORIDE; RUPATADINE
Phase II
3 trials-
RecruitingXinnate AB CommercialH-GLY-LYS-TYR-GLY-PHE-TYR-THR-HIS-VAL-PHE-ARG-LEU-LYS-LYS-TRP-ILE-GLN-LYS-VAL-ILE-ASP-GLN-PHE-GLY-GLU-OH
-
RecruitingCentre Hospitalier Universitaire De Nantes AcademicDEUCRAVACITINIB
-
RecruitingCentre Hospitalier Universitaire De Nantes AcademicCOLESTYRAMINE
Phase I (First in Human)
1 trial-
RecruitingInstitut National De La Sante Et De La Recherche Medicale AcademicAUTOLOGOUS KERATINOCYTES AND FIBROBLASTS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING COL7A1 CDNA
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Centre Hospitalier Universitaire De Nantes | Academic | 2 | Phase II | 2 |
| Xinnate AB | Commercial | 1 | Phase II | 1 |
| Rheacell GmbH & Co. KG | Commercial | 1 | Phase III | 1 |
| Institut National De La Sante Et De La Recherche Medicale | Academic | 1 | Phase I (First in Human) | 1 |
New trials by year
2023
1
2024
2
2025
2